Literature DB >> 12220493

E. coli dihydroorotate dehydrogenase reveals structural and functional distinctions between different classes of dihydroorotate dehydrogenases.

Sofie Nørager1, Kaj Frank Jensen, Olof Björnberg, Sine Larsen.   

Abstract

The flavoenzymes dihydroorotate dehydrogenases (DHODs) catalyze the fourth and only redox step in the de novo biosynthesis of UMP. Enzymes belonging to class 2, according to their amino acid sequence, are characterized by having a serine residue as the catalytic base and a longer N terminus. The structure of class 2 E. coli DHOD, determined by MAD phasing, showed that the N-terminal extension forms a separate domain. The catalytic serine residue has an environment differing from the equivalent cysteine in class 1 DHODs. Significant differences between the two classes of DHODs were identified by comparison of the E. coli DHOD with the other known DHOD structures, and differences with the class 2 human DHOD explain the variation in their inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220493     DOI: 10.1016/s0969-2126(02)00831-6

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  29 in total

1.  Oxygen reactivity in flavoenzymes: context matters.

Authors:  Claudia A McDonald; Rebecca L Fagan; François Collard; Vincent M Monnier; Bruce A Palfey
Journal:  J Am Chem Soc       Date:  2011-10-04       Impact factor: 15.419

Review 2.  Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.

Authors:  Margaret A Phillips; Pradipsinh K Rathod
Journal:  Infect Disord Drug Targets       Date:  2010-06

3.  Expression, purification and crystallization of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with orotate.

Authors:  Daniel Ken Inaoka; Eizo Takashima; Arihiro Osanai; Hironari Shimizu; Takeshi Nara; Takashi Aoki; Shigeharu Harada; Kiyoshi Kita
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-09-13

4.  Identification of New Human Malaria Parasite Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors by Pharmacophore and Structure-Based Virtual Screening.

Authors:  Elumalai Pavadai; Farah El Mazouni; Sergio Wittlin; Carmen de Kock; Margaret A Phillips; Kelly Chibale
Journal:  J Chem Inf Model       Date:  2016-03-08       Impact factor: 4.956

5.  Heme biosynthesis is coupled to electron transport chains for energy generation.

Authors:  Kalle Möbius; Rodrigo Arias-Cartin; Daniela Breckau; Anna-Lena Hännig; Katrin Riedmann; Rebekka Biedendieck; Susanne Schröder; Dörte Becher; Axel Magalon; Jürgen Moser; Martina Jahn; Dieter Jahn
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-19       Impact factor: 11.205

6.  Pyrimidine Pathway-Dependent and -Independent Functions of the Toxoplasma gondii Mitochondrial Dihydroorotate Dehydrogenase.

Authors:  Miryam Andrea Hortua Triana; Daniela Cajiao Herrera; Barbara H Zimmermann; Barbara A Fox; David J Bzik
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

7.  The dimeric dihydroorotate dehydrogenase A from Lactococcus lactis dissociates reversibly into inactive monomers.

Authors:  Mette Brimheim Ottosen; Olof Björnberg; Sofie Nørager; Sine Larsen; Bruce Allan Palfey; Kaj Frank Jensen
Journal:  Protein Sci       Date:  2002-11       Impact factor: 6.725

8.  Defects in vesicle core induced by escherichia coli dihydroorotate dehydrogenase.

Authors:  Sheila G Couto; M Cristina Nonato; Antonio J Costa-Filho
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

9.  Disruption of the proton relay network in the class 2 dihydroorotate dehydrogenase from Escherichia coli.

Authors:  Rebecca L Kow; Jonathan R Whicher; Claudia A McDonald; Bruce A Palfey; Rebecca L Fagan
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

10.  Roles in binding and chemistry for conserved active site residues in the class 2 dihydroorotate dehydrogenase from Escherichia coli.

Authors:  Rebecca L Fagan; Bruce A Palfey
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.